Six Navers Lab / Einsia benchmarks and the work they test
Compare the tasks, scoring and evidence behind six Einsia benchmarks, with complete Radar detail pages and original references.
Claire Radar
OncoTraj is a public benchmark for predicting acquired resistance to first-line osimertinib in EGFR-mutant non-small-cell lung cancer. It provides a harmonized dataset of 813 patients from three real-world sources, with locked splits, an evaluation harness, and six baselines, defining three tasks: 12-month progression classification, time-to-progression regression, and resistance mechanism classification.
Numeric results have not been collected for this source record. Use the paper, code or dataset below to check the task and experiments; this does not imply that the original work contains no results.
Catalog collected on 2026-10-14; resources and fields reflect that saved source.
Observed on: 2026-10-12
span-ai-labs/oncotraj · View source snapshot
Dated attention observations, not live counts or benchmark scores.
These are source-reported observations, not independent reruns by this site. Check the task version, evaluation protocol, unit and reporting date before comparing models. Results from different setups are not a universal ranking.
This source record has no numeric results in our collection. That does not mean a score of zero or that no public results exist. Consult the original resources above.